AsiaTIDES: Oligonucleotide and Peptide Research, Technology and Product Development
Where Global Oligonucleotide and Peptide Leaders Connect to Share Groundbreaking Science and Form Successful Business Collaborations
February 25 - February 27,--> 2014 · Tokyo, Japan
Updated: February 7, 2014
Agilent's Nucleic Acid Solutions Division offers industry leading experience to efficiently advance your lead oligo candidates from clinic to market with a common goal of patient health and safety. With Agilent, you always have peace of mind by partnering with a company that has the financial resources, stability and vision required for long-term success. Contact us at: firstname.lastname@example.org and find out why the world's most revolutionary biotech companies and their Big Pharma partners are choosing Agilent Technologies to develop and commercialize their oligo APIs.
Driven by Excellence, Guided by Experience. With over 15 years of oligonucleotide manufacture, more than 1000 sequences produced at scale, and industry leading experience in validation and commercial product requirements, Avecia is proud to continue our tradition of 'Experience and Reliability from the First Gram.' Avecia's commitment to the future of the oligonucleotide market is driven by innovative ideas and flexible solutions, designed to provide our customers with the best in service, quality, and technology. From pre-clinical stages to commercial launch, you can count on Nitto Avecia.
Established in 1981, ChemGenes, an ISO9001 certified company, has consistently provided the highest quality Phosphoramidites and Solid Supports in the market and continues to lead the industry in oligonucleotide reagent manufacturing. Our Massachusetts facility is setup for therapeutic grade phosphoramidite production for GMP grade oligonucleotide manufacturing. Currently, our bulk synthesis capacities are 150kg/base yearly for 2'-O-Methyl and DNA phosphoramidites and 60kg/base yearly for RNA phosphoramidites. Additionally, ChemGenes carries the widest variety of modified phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic Acid research. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.
Lonza offers the life sciences market a full range of bioresearch products, development services and manufacturing for active ingredients. For 30 years we have been helping companies increase product quality, improve production processes, navigate regulatory hurdles, lower costs, and get to market faster. From early development to in-market supply, our complete development services, industry-leading manufacturing processes, broad technology platform and lifecycle management experience can help take your product to the next level. For flexible, high-quality manufacturing, development services and products, we can help.
For more than 16 years, BioSpring has been providing manufacturing and analytical services for the oligonucleotide market. We manufacture an entire range of unmodified and modified oligonucleotides from mg to multi-kg quantities for the use in therapeutic (GMP) and diagnostic applications (ISO 13485 certified), molecular biology, and research and development. In addition, we have a dedicated analytical team and employ state of the art techniques for fully testing and characterizing oligonucleotides and oligonucleotide containing products. For additional information, contact us via email: email@example.com.
Sanofi CEPiA = Success with your peptide or oligonucleotide project! Access the Sanofi global manufacturing network through Sanofi's dedicated CMO business unit, CEPiA. Your project will benefit from the same proven capabilities supporting development of Sanofi oligonucleotide and peptide products such as Lyxumia® (lixisenatide). Efficient integration of API and drug product manufacturing - including vials, pre-filled syringes, devices and packaging - makes CEPiA your one-stop partner of choice.
GeneDesign offers contract manufacturing of various therapeutics and diagnostics oligonucleotide including PEGylation, peptide conjugation and ligand conjugation from screening use to hundreds gram GMP manufacturing with sterilized condition. With our widely experience and challenge mid to the new technology area, we can contribute to your successful oligo therapeutics development. We also have launched new oligo-synthesizer based on well expertise for long RNA manufacturing.
Spotlight Presentation Sponsors
Networking Reception and Dinner Co-Sponsor
Refreshment Break Sponsors
Copyright IBC Life Sciences, a part of Informa Life Sciences Group.Phone: 800.390.4078Email: firstname.lastname@example.org